FIELD: medicine, oncology. SUBSTANCE: invention relates to an antitumor therapy and proposes an antitumor preparation containing synergetically acting the tumor necrosis alpha-factor and hematoporphyrin derivative at their molar ratio = 1:1. The proposed complex preparation shows the enhanced antitumor activity and affinity to malignant tissue and decreased toxicity as compared its individual components. EFFECT: enhanced antitumor activity of an agent. 4 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTICANCER DRUG BASED ON NANOPARTICLES BEARING RECOMBINANT HUMAN TUMOUR NECROSIS FACTOR ALPHA | 2008 |
|
RU2386447C1 |
| ANTITUMOUR AGENT BASED ON BIODEGRADABLE NANOPARTICLES CARRYING A RECOMBINANT HUMAN TUMOR NECROSIS FACTOR ALPHA | 2018 |
|
RU2691938C1 |
| OCTA-4,5-CARBOXYPHTHALOCYANINES AS PHOTOSENSITIZING AGENTS FOR PHOTODYNAMIC THERAPY | 2000 |
|
RU2193563C2 |
| SULFOSUBSTITUTED PHTHALOCYANINES AS PHOTOSENSITIZING AGENTS FOR PHOTODYNAMIC THERAPY | 1999 |
|
RU2183635C2 |
| OCTA-4,5-CARBOXYLIC ACID PHTHALOCYANINE COBALT ESTERS, THEIR INCLUSION COMPLEXES WITH BETA-CYCLODEXTRIN PROPYLENE GLYCOL ESTER AND METHOD OF SUPPRESSION OF TUMOR GROWTH | 2000 |
|
RU2172319C1 |
| MEANS TO INHIBIT TUMOR GROWTH | 1995 |
|
RU2106146C1 |
| ANTITUMOR AGENT | 2015 |
|
RU2609871C1 |
| PREPARATION FOR DECREASING TOXICITY OF CHEMICALLY SYNTHESIZED ANTITUBERCULAR MEDICINAL PREPARATIONS | 2000 |
|
RU2190417C2 |
| MOLECULAR VECTOR FOR DELIVERING GENES TO TARGET CELLS | 2000 |
|
RU2190018C2 |
| METHOD OF PREPARING NUCLEOPROTEID COMPLEXES FROM BIRD EMBRYOS SHOWING IMMUNOTROPIC AND RADIOPROTECTIVE ACTIVITY | 1995 |
|
RU2110267C1 |
